Goldman Sachs cuts total voting rights in Carl Zeiss Meditec to 4.97% from 5.54%
GS•Goldman Sachs reduced its total voting rights in Carl Zeiss Meditec to 4.97% from 5.54% as of Nov. 2, 2026. Rights through instruments fell to 4.29% from 4.86%, while rights attached to shares remained at 0.68%.
1. Voting rights decline
Goldman Sachs reduced its total voting rights in Carl Zeiss Meditec to 4.97% from 5.54% as of Nov. 2, 2026. Voting rights through instruments fell to 4.29% from 4.86%, while voting rights attached to shares remained unchanged at 0.68%.
